<DOC>
	<DOCNO>NCT00620074</DOCNO>
	<brief_summary>This study test effectiveness safety give two antifungal agent ( voriconazole anidulafungin ) together treat invasive aspergillosis patient unable tolerate polyene therapy .</brief_summary>
	<brief_title>Study Test Combination Voriconazole Anidulafungin Patients Who Have , Are Thought Have , Invasive Aspergillosis Who Are Unable Take Common Antifungal Therapy ( Polyene )</brief_title>
	<detailed_description>The study terminate January 12 , 2009 due overall low rate enrollment . The decision terminate trial base safety concern . Patients enrol study prior January 12 , 2009 allow remain study complete participation specify protocol .</detailed_description>
	<mesh_term>Aspergillosis</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<mesh_term>Anidulafungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>Proven probable invasive aspergillosis . Patient intolerant polyene therapy . Patients invasive aspergillosis 30 day time study entry . Patients uncontrolled bacterial viral infection time study entry . Patients significant liver dysfunction take certain medication interact voriconazole .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>invasive aspergillosis , opportunistic mold infection</keyword>
</DOC>